Search
SOLACI Congress
Highlighted PresentationsPharmacologyAntiplatelet

SOLACI-SBHCI 2023 | Patient-centered Selection Anti-platelet Treatment for ACS-PCI Patients: Real World Evidence of Prasugrel – Dr. Roxana Mehran

solaci
solaci
136
0

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress.

In this case, check the presentation by Dr. Roxana Mehran, entitled “Patient-centered Selection Anti-platelet Treatment for ACS-PCI Patients: Real World Evidence of Prasugrel”.

Roxana-Mehran-patient-centered-solaci-sbhci-2023

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
SOLACI-SBHCI 2023 | High bleeding and ischemic dilemma: how to evaluate and predict? – Dr. Roxana Mehran
Next article
SOLACI-SBHCI 2023 | Tips and Tricks with Renal Denervation – Dr. María Sanalí Paiva
solaci
solaci

More articles by this author

Direct Oral Anticoagulants for Ventricular Thrombus After STEMI

Dr. Omar Tupayachi - 0
While the incidence of intracavitary thrombi after acute myocardial infarction (AMI) has decreased thanks to optimized primary angioplasty times, some studies report rates of...

AHA 2024 | VANISH2 Trial

Dr. Omar Tupayachi - 0
Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

Dr. Omar Tupayachi - 0
It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes

Dr. Andrés Rodríguez - 0
Various studies and registries have previously shown the impact of post-percutaneous coronary intervention (PCI) complications on the survival of patients with ST-segment elevation acute...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Acute coronary syndromes

Direct Oral Anticoagulants for Ventricular Thrombus After STEMI

While the incidence of intracavitary thrombi after acute myocardial infarction (AMI) has decreased thanks to optimized primary angioplasty times, some...
Dr. Omar Tupayachi -
SOLACI Sessionsspot_img

Recent Articles

Timing in Complete Revascularization in Acute Coronary Syndrome: BIOVASC 2-Year Followup

Dr. Omar Tupayachi - 0
The concept of complete revascularization (CR) has been comprehensively studied, leading to diverse approaches and debates on optimal timing.  The BIOVASC trial explored the ideal...

DCB-BIF Trial: Randomized Study of Side Branch Drug-Coated Balloon Angioplasty Following Provisional Stenting

Dr. Omar Tupayachi - 0
Coronary bifurcations present technical challenges that should be addressed for adequate coronary geometry. The first treatment option for complex coronary bifurcations (according to the...

Coronary Sinus Reducer for Refractory Angina: Notes from the REDUCER-I Study

Dr. Omar Tupayachi - 0
Refractory angina is defined as the presence of ischemic symptoms that cannot be controlled through optimal medical therapy (OMT) or interventional treatment. Patients who...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Timing in Complete Revascularization in Acute Coronary Syndrome: BIOVASC 2-Year Followup

Dr. Omar Tupayachi - 0
The concept of complete revascularization (CR) has been comprehensively studied, leading to diverse approaches and debates on optimal timing.  The BIOVASC trial explored the ideal...

DCB-BIF Trial: Randomized Study of Side Branch Drug-Coated Balloon Angioplasty Following Provisional Stenting

Dr. Omar Tupayachi - 0
Coronary bifurcations present technical challenges that should be addressed for adequate coronary geometry. The first treatment option for complex coronary bifurcations (according to the...

Coronary Sinus Reducer for Refractory Angina: Notes from the REDUCER-I Study

Dr. Omar Tupayachi - 0
Refractory angina is defined as the presence of ischemic symptoms that cannot be controlled through optimal medical therapy (OMT) or interventional treatment. Patients who...

Institutional News

New Virtual Event from CHIP LATAM SOLACI: Mexico Chapter

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new educational activity organized by the Department of Complex Percutaneous Coronary...

Miami Valves 2025

solaci - 0
Between January 30 and February 1, 2025, the Miami Valves 2025 will take place in Miami, Florida, USA, at the Miami Marriott Biscayne Bay...

January 23 – SOLACI Medtronic Webinar: Visualizing Different PCI Techniques for Bifurcations from a Totally Different Perspective

solaci - 0
A new virtual educational event is coming, organized by the Latin American Society of Interventional Cardiology with the support of Medtronic. This time, we will...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy